Summary
Infection by SARS-CoV-2 virus often induces the dysregulation of immune responses, tissue damage, and blood clotting. Engineered biomaterials from the nano- to the macroscale can provide targeted drug delivery, controlled drug release, local immunomodulation, enhanced immunity, and other desirable functions to coordinate appropriate immune responses and to repair tissues. Based on the understanding of COVID-19 disease progression and immune responses to SARS-CoV-2, we discuss possible immunotherapeutic strategies and highlight biomaterial approaches from the perspectives of preventive immunization, therapeutic immunomodulation, and tissue healing and regeneration. Successful development of biomaterial platforms for immunization and immunomodulation will not only benefit COVID-19 patients, but also have broad applications for a variety of infectious diseases.
【저자키워드】 Vaccine, immunomodulation, drug delivery, tissue regeneration, 【초록키워드】 SARS-CoV-2, immune response, Diseases, Immunity, SARS-CoV-2 virus, Local, progression, immunization, COVID-19 disease, immune responses, therapeutic, platform, function, COVID-19 patients, Blood, dysregulation, tissue, tissue damage, tissues, Perspective, approach, benefit, highlight, variety, induce, 【제목키워드】 COVID-19, Infectious disease,